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Abstract 
Extraskeletal myxoid chondrosarcoma (EMC) is a malignant soft-tissue neoplasm rarely described in the head and 
neck region of children and adolescents. We describe a case of EMC affecting the masticator space and a literature 
review. A 13-year-old boy who presented a large painless, diffuse mass causing progressive midfacial asymmetry 
of 6 months duration. Histopathological evaluation revealed a multinodular lesion, containing scattered round va-
cuolated tumor cells dispersed in an abundant myxoid stroma, separated by fibrous septae. Immunohistochemical 
analysis revealed positivity for vimentin, neuron-specific enolase, and chromogranin. The Ki-67 labelling index 
was 42%. The patient was treated surgically with tumor resection followed by adjuvant local radiotherapy. The 
patient died 1 year after initial diagnosis due to locoregional tumor dissemination. EMC should be considered in 
the differential diagnosis of myxoid neoplasms in the head and neck region.
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Introduction
Extraskeletal myxoid chondrosarcoma (EMC) is a rare 
myxoid tumor accounting for less than 3% of all soft 
tissue sarcomas (1). Despite the terminology, EMC does 
not present convincing evidence of cartilaginous diffe-
rentiation, and recently, a neuroectodermic origin has 
been proposed (2). Most cases exhibit the specific reci-
procal translocation t(9;22) (3).
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EMC mainly affects the lower limbs of male patients in 
their fifth and sixth decades of life, presenting as a pa-
inful and tender soft-tissue swelling (1-3). Rarely, EMC 
occurs in pediatric patients (4) or in other anatomical si-
tes including the head and neck region (3). EMC shows 
a high signal in T2 weighted magnetic resonance images 
(MRI), being directly proportional to its myxoid com-
ponent (5).
Microscopically, the tumor cells of EMC typically pre-
sent eosinophilic granular, frequently vacuolated cyto-
plasm with round to oval nuclei, morphologically res-
embling lipoblasts, immersed in a myxoid stroma in a 
multilobular arrangement, which is separated by fibrous 
septae (6-7). The immunophenotype of EMC include 
positivity for vimentin and variable staining for S-100 
and neuroendocrine markers (3,6).
The most effective treatment for EMC is wide surgical 
excision since most of the cases show poor response to 
chemotherapy and radiotherapy (7). Local recurrence 
and distant metastases are common, with some cases 
presenting a prolonged survival (1,6-7).
To the best of our knowledge 33 EMC cases of the head 
and neck region have been reported in the literature, 
most of them affecting the neck, nasal cavity and intra-
cranial cavity (Table 1) (2,7-33). Only four cases affec-
ted pediatric patients, (9,20,25,29) with two previous ca-
ses affecting the infratemporal fossa and parapharyngeal 
space (19,21).
Case Report
A 13-year-old male presented with a rapid enlarging 
painless diffuse mass located at the right midface and 
parotid region over the last 6 months. Slight asymme-
try of the right commissure, trismus and mandibular 
asymmetry were evident on initial examination. There 
were no evidences of regional or distant metastasis. Past 
medical history included a previous surgical treatment 
attempt in his native country Honduras, three months 
prior to his referral (Fig. 1A). T1 weighted MRI showed 
a large hyperintense mass measuring 7 x 5 cm, located 
centrally at the right masticator space with extention into 
the mandibular ramus, masseter and pterigoyd muscles, 
parotid gland and parapharyngeal space. Contrast T2 
weighted MRI exhibited a high signal with a multinodu-
lar and infiltrative pattern (Fig. 1B).
An incisional intraoral biopsy was performed under lo-
cal anesthesia. The histopathological examination revea-
led multiple nodules containing tumor cells, immersed 
in an abundant myxoid stroma separated by fibrous sep-
tae. The tumor cells varied in shape from round to elon-
gate, most displaying abundant eosinophilic cytoplasm 
and round to ovoid excentrically located nuclei, which 
showed homogeneously distributed chromatin and in-
conspicuous nucleoli. Other cell types were recognized, 
mainly spindle, epithelioid and lipoblast-like cells (Fig. 
2). The mitotic rate was low, averaging two mitotic figu-
res per 10 high-power fields. Periodic acid-Schiff (PAS), 
with and without prior diastase digestion, demonstrated 
that the granular cytoplasmic material was glycogen. 
Immunohistochemical analysis (Table 2), showed posi-
tivity for vimentin, neuron-specific enolase (NSE), and 
chromogranin; whereas AE1/AE3, epithelial membrane 
antigen (EMA), S-100, desmin, muscle-specific actin 
(HHF35), CD57, Glucose transporter type 1 (Glut-1), 
synaptophysin, p53, p63, glial fibrillary acidic protein 
(GFAP), and podoplanin (D2-40) were negative. The 
Ki-67 labelling index was 42% after evaluation of 1000 
cells per five high-power fields (Fig. 3). Fluorescent 
in situ hybridization was not performed; however, the 
histomorphological and immunohistochemical findings 
supported a final diagnosis of EMC.
There were no evidences of regional or distant metas-
tases, and the patient was treated with en-bloc surgical 
resection, including ipsilateral hemi-mandibulectomy, 
total parotidectomy with facial nerve dissection, neck 
dissection level I to IV and reconstruction with a man-
dibular plate and major pectoralis flap. Macroscopically, 
the specimen measured 8 x 6 x 5 cm consisting of an 
irregularly shaped mass attached to the mandibular ra-
mus, with a multilobular and gelatinous rubbery tissue. 
Focally, the tumor was present in one surgical margin, 
immediately anterior to the mandibular condyle. Mi-
croscopic evaluation revealed the same histopathologi-
cal features found in the incisional biopsy. The patient 
received adjuvant radiotherapy but died after 1 year of 
follow-up due to complications of locoregional tumor 
dissemination to the skull base.
Discussion
Extraskeletal myxoid chondrosarcoma (EMC) is a rare 
myxoid soft tissue sarcoma first described as a distinct 
entity by Enzinger & Shiraki (1972) (2-3). Since the ini-
tial description, skeletal myxoid chondrosarcoma and 
EMC are considered different entities; (34) in fact, the 
latter does not show convincing evidences of cartilagi-
nous origin (1-3). Moreover, most EMC present the reci-
procal translocation t(9;22)(q22;q12) that recombines the 
genes nuclear receptor subfamily 4, group A, member 3 
(NR4A3, also termed TEC, NOR1 or CHN [9q22]) and 
Ewing sarcoma region 1 (EWS [22q12]).2,8 Other cyto-
genetic subgroups has been less commonly described, in-
cluding t(9;17)(q22;q11) and t(9;15)(q22;q21) (2,3,8).
EMC of the head and neck region is rare, with only 33 
cases reported in the English language literature to this 
date, including the present case (Table 1). In the head 
and neck region, the most common sites of EMC are the 
nasal cavity and neck, followed by intracranial cavity, 
clavicular region, maxilla, sphenoid sinus and temporal 
bone. To the best of our knowledge, there is only one 
previous report of EMC involving the masticator space 
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N Authors Age (y)/ 
Gender 
Location Treatment Recurrence, 
follow-up 
1 Englert et al. (1978)8 43/M Mandibular metastasis Palliative NR 
2-3 Tsuneyoshi  et al. (1981)9 16/M Nasal cavity S Yes, 5 months - Died 
66/M Neck S No, 2 months 
4 Charabi  et al. (1989)10 34/F Temporal bone S* No, 18 months 
5 Liu-Shindo  et al. (1989)11 51/F Skin, over the mentum S, Rx No, 15 months 
6 Jawad  et al. (1991)12 45/M Maxillary sinus S No, 18 months 
7 Salcman  et al. (1992)13 28/F Intracranial S, Rx Yes, 22 months 
8 Sato  et al. (1993)14 43/F Intracranial S, Rx, Ch Yes, NR - Died 
9-10 Antonescu  et al. (1998)15 53/M Neck S No, 4 months 
82/M Neck S Yes, 60 months – Died 
11 Worley  et al. (1999)16 42/M External auditory meatus S No, 9 months 
12 Oshiro  et al. (2000)17 66/M Neck, scapula NR No, 12 months 
13 De Las Casas  et al. (2000)18 44/M Spheinodal sinus S, Rx No, 16 months 
14-15 Goh  et al. (2001)2 65/M Epidural NR NR 
70/M Supraclavicular NR NR 
16 Bahri  et al. (2002)19 67/F Parapharyngeal space S, Rx No, 7 months 
17 González-Lois  et al. (2002)20 17/F Intracranial S, Rx Yes, 20 months 
18 Acero  et al. (2003)21 22/F Infratemporal fossa S, Rx No, 36 months 
19-20 Jérôme-Marson  et al. (2003)22 67/M Nasal cavity S, Rx NR, 7 months 
71/F Sphenoidal sinus S, Rx NR, 4 months 
21 Cummings  et al. (2004)23 63/M Jugular foramen NR NR 
22 Ceylan  et al. (2006)24 35/F Nasal cavity S No, 9 months 
23 Jörg  et al. (2006)25 8/M Maxilla S No, 18 months 
24 Saint-Blancard  et al. (2006)26 67/F Neck S NR 
25 Nakazora  et al. (2006)27 48/M Clavicle S No, 36 months 
26 Betz  et al. (2007)28 88/NR Nasal septum S No, 13 months 
27 Kim  et al. (2007)29 10/M Sinonasal cavity S, Rx* NR 
28 Drilon  et al. (2008)7 NR NR NR NR 
29 O’Brien  et al. (2008)30 26/F Cerebellopontine angle S, Rx No, 12 months 
30 Willems  et al. (2008)31 32/M Neck NR NR 
31 Deik  et al. (2009)32 94/M Supraclavicular NR NR 
32 Kaplan  et al. (2010)33 37/F Maxillary sinus S, Rx No, 18 months 
33 Oh  et al. (2013)35 62/F Neck S NR 
34 Current case (2017) 13/M Masticator space S, Rx Yes, 12 months – Died 
Table 1: Clinical features of 34 cases of extraskeletal myxoid chondrosarcomas of the head and neck region reported in the English language 
literature and the present case.
(21). Most of the patients presenting EMC are in their 
fifth to seventh decade of life. At present, there are only 
3 reported cases affecting the oral and maxillofacial re-
gion in pediatric patients, (25,29) including our case. 
Tumors involving the facial region are usually diagno-
sed after reaching large size, destroying underlying bone 
with invasion into the subcutaneous soft tissues (20-
21,29). The most commonly accepted treatment is surgi-
cal resection, but due to technical complexities related to 
this anatomical region, complete tumor resection often 
is not achieved, resulting in poorer prognosis(20-21). In 
the present case, the superior margin was microscopica-
lly compromised, and the adjuvant radiation therapy did 
not prevent local tumor dissemination, causing the death 
of the patient. Nevertheless, Acero et al. (21) reported a 
case of EMC affecting the infratemporal fossa and mas-
ticator space of a 22-year-old female patient, which was 
treated by surgical excision followed by adjuvant radio-
therapy and no signs of recurrence was seen 3 years of 
post-treatment follow-up.
Imaging features of EMC include a multi-nodular soft 
tissue proliferation with high intensity signal on T2-
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Fig. 1: Clinical and imaging features of extraskeletal myxoid chondrosarcoma: (A) Patient 
with EMC of the masticator space showing a large painless swelling involving the right mid-
face and parotid region. Note the deviation of the right commissure. (B) Inverted image of 
contrasted T2-wheighted MRI showing a large multinodular tumor with trabecular configura-
tion infiltrating adjacent structures (coronal section).
A B
Fig. 2: Microscopical features of extraskeletal myxoid chondrosarcoma: (A) Myxoid tumor nodules 
separated by fibrous septae, containing neoplastic cells (HE, x25). (B) Oval to round tumor cells of 
different sizes showing lightly eosinophilic to clear cytoplasm within a myxoid stroma. Hypercel-
lular areas are distributed along the periphery of the myxoid nodules (HE, x100). (C) Areas of the 
tumors contain round to ovoid empty spaces resembling adipose tissue on lower power. (HE, x100). 
(D) Detail of lipoblast-like cells presenting eosinophilic, vacuolated cytoplasm and round displaced 
nuclei (HE, x400). 
weighted MRI and heterogeneous enhancement on 
contrasted images, (5) as observed in the present case. 
Grossly, the majority of EMC presents as a large well 
demarcated tumor with nodular areas of gelatinous 
appearance, (5,9) as also found in the present case.
Microscopically the nodular gelatinous areas correspond 
to the myxoid stroma, demarcated by fibrous septa.1-3. 
Tumor cells are immersed on this matrix, isolated or 
more typically forming interconnecting cords or clus-
ters. The cells show granular or vacuolated eosinophilic 
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Antibody Source/Clone Dilution Results 
Vimentin Dako®a, Vim 3B4 1:400 ++ 
NSE Dako®a, BBS/NC/VI-H14 1:800 + 
Chromogranin Dako®a, polyclonal 1:800 + 
Pan-CK Dako®a, AE1/AE3 1:500 Neg 
EMA Dako®a, E29 1:400 Neg 
Desmin Dako®a, D33 1:1000 Neg 
Synaptophysin Dako®a, SY38-1/100 1:100 Neg 
CD57 Dako®a, NK 1 1:800 Neg 
Glut-1 Biosystems®b, polyclonal 1:100 Neg 
S100 Dako®a, polyclonal 1:10000 Neg 
SMA Dako®a, 1A4 1:400 Neg 
MSA Dako®a, HHF-35 1:800 Neg 
p53 Dako®a, DO-7 1:200 Neg 
p63 Dako®a, 4A4 1:600 Neg 
GFAP Dako®a, 6F2 1:400 Neg 
D2-40 Dako®a, D2-40 1:100 Neg 
Ki-67 Dako®a, MIB-1 1:100 + (42%) 
Table 2: Antibodies used for immunohistochemistry and results positive/negative in extraskeletal 
myxoid chondrosarcoma of the masticator space.
CK, Cytokeratin; EMA, Epithelial membrane antigen; NSE, Neuron-specific enolase; SMA, Alfa-
smooth muscle actin; MSA, Muscle-specific actin; GFAP, Glial fibrillary acidic protein; +, positive, 
++, strong positive; aDako A/S, Glostrup, Denmark. bDiagnostic ByoSystems, Pleasanton, CA.
Fig. 3: Immunohistochemical profile of extraskeletal myxoid chondrosarcoma: (A) vimentin (IHC, 
x400), (B) neuron-specific enolase (IHC, x400), (C) chromogranin (IHC, x400). (D) Nuclear staining 
for Ki-67 with index labeling of 42% (IHC, x400).
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cytoplasm, containing round nuclei with inconspicuous 
nucleoli (1-3,6). Characteristically, diastase-sensitive 
PAS positive staining demonstrates glycogen in the tu-
mor cells. The classic EMC morphology might not be 
seen in some cases, where more cellular areas with mi-
nimal myxoid matrix and tumor cells with epithelioid, 
rhabdoid and spindle cell features are observed (3). Mi-
totic figures are uncommon while intratumoral haemorr-
hage can be observed (1,3,6). The present case showed 
the classic morphology of EMC, which facilitated the 
diagnosis.
The EMC immunophenotype includes diffuse positi-
vity for vimentin (77%), focal positivity for synapto-
physin (59%), NSE (54%) and S-100 protein (31%), 
while chromogranin is expressed in a minority of cases. 
Epithelial markers such as cytokeratins and EMA are 
usually negative (2,6). Expression of these markers and/
or demonstration of neuro-secretory granules by elec-
tron microscopy support the hypothesis of a possible 
neuroendocrine differentiation (3), indicating that the 
term chondrosarcoma is inappropriate. The present case 
showed the typical histological morphology, and positi-
vity for vimentin, NSE and chromogranin, confirming 
the diagnosis. The Ki-67 index found on this case can be 
considered high (42%), explaining in part the aggressive 
clinical behavior, however, the affected anatomical re-
gion and initial incomplete surgical treatment also con-
tributed to the fatal disease progression. The extraskele-
tal site was supported by imaging evaluation, and was 
confirmed during the surgical procedure.
EMC may show typical, alternating hypercellular and 
hypocellular areas, and these aspects should be consi-
dered in the differential diagnosis (6). As for cases of 
typical EMC, our histological differential diagnosis 
included myxoid tumors such as chordoma, parachor-
doma, myxoid liposarcoma, and myxofibrosarcoma. 
Because of the patient´s age and the epithelioid morpho-
logy of some tumor cells, embryonal rhabdomyosarco-
ma, epitheliod sarcoma and extrarenal rhabdoid tumor 
were also considered, but as less likely possibilities. 
Histological characteristics as absence of physalliferous 
cells, elongated curvilinear blood vessels, salivary gland 
duct-like structures, rhabdomyoblasts, globoid cytoplas-
mic inclusions of rhabdoid cells and cytokeratin, S-100 
and myogenic markers negativity helped to exclud these 
possibilities (48). In EMC cases with non-classic mor-
phology or hypercellular-predominant areas, molecular 
studies such as FISH or RT-PCR may be required to con-
firm the diagnosis (2,3).
As mentioned above, the treatment of choice for patients 
with EMC is surgical tumor resection with clear margins 
(7,21). Although EMC was previously considered a low-
grade sarcoma, currently its prognosis has been reported 
as unfavorable with a high mortality rate, particularly for 
pediatric patients and tumors larger than 10 cm (1,3-4). 
Almost half of EMC cases present local recurrence and 
distant metastasis, despite the estimated 5 years survival 
rate of 90% (6). In cases with microscopically positive 
margins, high doses of adjuvant radiation therapy have 
been useful for the control of local tumor dissemination 
in contrast with chemotherapy, which plays limited or no 
role (7). In the present case, the surgical resection of a 
large tumor involving the masticator space of a pediatric 
patient was technically difficult, and was followed by ad-
juvant radiotherapy. Unfortunately, the patient died after 
1 year of follow-up due local recurrence of disease.
In summary, we report a rare case of EMC affecting the 
masticator space and adjacent structures of a pediatric 
patient with unfavorable outcome. Clinicians and patho-
logists should be aware to consider EMC in the diffe-
rential diagnosis of myxoid neoplasms in the head and 
neck region.
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